Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EJ7U
|
||||
Former ID |
DIB009027
|
||||
Drug Name |
CPP-115
|
||||
Synonyms |
GABA aminotransferase inhibitors (oral), Northwestern University/Catalyst Pharmaceutical Partners; Vigabatrin derivatives (oral, neurological diseases), Northwestern University; Vigabatrin derivatives (oral, drug addiction/epilepsy/neuropathic pain), Catalyst Pharmaceutical Partners
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Catalyst pharmaceutical partners
|
||||
Structure |
Download2D MOL |
||||
Formula |
C7H9F2NO2
|
||||
InChI |
InChI=1S/C7H9F2NO2/c8-6(9)4-1-3(7(11)12)2-5(4)10/h3,5H,1-2,10H2,(H,11,12)/t3-,5-/m0/s1
|
||||
InChIKey |
CBSRETZPFOBWNG-UCORVYFPSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 4-aminobutyrate aminotransferase, mitochondrial | Target Info | Inhibitor | [549893] | |
References | |||||
Ref 523732 | ClinicalTrials.gov (NCT01493596) A Safety, Tolerability and Pharmacokinetic Study of CPP-115. U.S. National Institutes of Health. | ||||
Ref 543038 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8284). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.